D-0508-2019 Class II Terminated

Recalled by US Compounding Inc — Conway, AR

FDA drug recall D-0508-2019 was initiated by US Compounding Inc on Jan 29, 2019 and is designated Class II. Reason for recall: Lack of assurance of sterility. The recall status is terminated (terminated Jan 24, 2020). Affected quantity: 1686 syringes.

Recall Details

Product Type
Drugs
Report Date
Feb 27, 2019
Initiation Date
Jan 29, 2019
Termination Date
Jan 24, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1686 syringes

Product Description

Ephedrine Sulfate, 50 mg/10 mL, 10 mL Single Use Syringe, Rx only, US Compounding Pharmacy 1270 Don's Lane Conway, AR 800-718-3588, Barcode: 62295308407

Reason for Recall

Lack of assurance of sterility.

Distribution Pattern

U.S.A. Nationwide

Code Information

Lot: 20181812@2 BUD: 06/16/2019

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0508-2019
openFDA file date
Nov 3, 2026
Loaded by RegDataLab
Nov 4, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0508-2019. Report a data issue: hello@regdatalab.com.